Loading
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Mar 2025 for Prelude Therapeutics Inc, €433k.
Filing timeline
BuySaleKrishna Vaddi
Insider track record
Disclosed buys
15
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-9.6%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Krishna Vaddi: trading record in brief
All filings by Krishna Vaddi on record concern Prelude Therapeutics Inc. In total, 19 filings cover trades dated from 29 September 2020 to 25 March 2025.
No open-market sale appears; the market trades are 15 purchases worth €813k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2025 to date brings 9 purchases and no sales.
In size, the median ticket on the buying side is €12k. Of 15 purchases, 9 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 27 March 2025, the filings show an open-market purchase worth €433k in Prelude Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Krishna Vaddi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
675,000 shares@ US$0.692546.8% of flowCommon StockSEC:0001562180-25-002778:0
Canonical exit: 23 Jun 2025 (T+90)
5,416 shares@ US$0.72940.4% of flowCommon StockSEC:0001562180-25-002697:0
Canonical exit: 18 Jun 2025 (T+90)
29,999 shares@ US$0.75442.3% of flowCommon StockSEC:0001562180-25-002541:0
Canonical exit: 12 Jun 2025 (T+90)
47,500 shares@ US$0.71043.3% of flowCommon StockSEC:0001562180-25-002392:0
Canonical exit: 10 Jun 2025 (T+90)
5,000 shares@ US$1.20870.6% of flowCommon StockSEC:0001562180-25-000031:0
Canonical exit: 31 Mar 2025 (T+90)
10,000 shares@ US$1.201.2% of flowCommon StockSEC:0001562180-25-000008:0
Canonical exit: 30 Mar 2025 (T+90)
100,000 shares@ US$0.93219.6% of flowCommon StockSEC:0001562180-24-008531:0
Canonical exit: 18 Mar 2025 (T+90)
1,000 shares@ US$5.01140.5% of flowCommon StockSEC:0001562180-23-004517:0
Canonical exit: 22 Aug 2023 (T+90)
11,856 shares@ US$5.636.7% of flowCommon StockSEC:0001562180-23-004474:0
Canonical exit: 21 Aug 2023 (T+90)
19,188 shares@ US$5.130610.0% of flowCommon StockSEC:0001562180-22-008404:0
Canonical exit: 20 Mar 2023 (T+90)
8,000 shares@ US$12.129410.2% of flowCommon StockSEC:0001209191-21-069547:0
11 of 11 declarations
